News

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...
Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.
The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...
In a report released today, Benjamin Jackson CFA from Jefferies maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €120.00. The company’s sh ...
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €110.00. The company’s shares closed yesterda ...
June 3, 2025 expert reaction to observational study on low calorie diets and depressive symptoms . An observational study published in BMJ Nutrition, Prevention & Health looks at ...
Skyline view of the City of London financial district from the viewpoint in Greenwich Park in London, United Kingdom. This is ...
Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...
This article summarizes recent developments in the health sector, including major acquisitions, drug trial results, and ...
The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...
At CTO West Coast an expert from Genentech outlined the company’s net zero goals, efforts, challenges and initiatives ...